Rapid and Specific Cell-Surface Anchoring of Gold Nanostars for Photoacoustic BMSC Imaging
Renhao Xu , Yanmei Cai , Xiaobin Dong , Xuezhi Wang , Wenyi Zheng , Ning Zhang , Yanni He , Hongmei Liu
BIO Integration ›› 2026, Vol. 7 ›› Issue (1) : 19
Background: Bone marrow mesenchymal stem cell (BMSC) therapy holds great promise for regenerative medicine, but its clinical translation is hindered by the lack of non-invasive, real-time methods to track transplanted cell fate in vivo. Although photoacoustic (PA) imaging offers deep-tissue penetration and high sensitivity, existing cell-labeling strategies relying on endocytosis of contrast agents have drawbacks of prolonged incubation times and variable efficiency, thus potentially compromising cell viability and function.
Methods: To address these limitations, we developed a rapid, bioorthogonal pre-labeling strategy. Azide (N3) groups were first metabolically engineered onto BMSC surfaces. Subsequently, dibenzocyclooctyne (DBCO)-functionalized gold nanostars (Au-star-DBCO) were conjugated to the cells via a highly efficient, copper-free click reaction, thereby enabling covalent membrane anchoring.
Results: This approach achieved rapid and specific stem cell labeling within 3 h, with an efficiency of 83.1% ± 0.67. The labeling process did not impair BMSC viability or multilineage differentiation potential. The Au-star-DBCO-labeled BMSCs generated strong, concentration-dependent PA signals both in vitro and in a rat subcutaneous model, and enabled dynamic monitoring for at least 72 h post-transplantation. The specificity of the bioorthogonal reaction provided a significantly higher signal-to-noise ratio than passive uptake methods.
Conclusions: We successfully established a biocompatible and efficient platform for stem cell tracking by integrating metabolic glycoengineering, bioorthogonal chemistry, and nanostar-enhanced PA imaging. This strategy overcomes key limitations of traditional endocytosis-based labeling, and offers a rapid, specific, and functional cell-compatible tool for sensitive, longitudinal in vivo monitoring. This platform may advance precise assessment of cell therapies and facilitate their clinical application.
Bone marrow mesenchymal stem cells / gold nanostars / photoacoustic
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
/
| 〈 |
|
〉 |